Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb)
Introduction TheTADAlafil treatment for Fetuses with early-onset growth Restriction: multicentrer, randomizsed, phase II trial (TADAFER II) study showed the possibility of prolonging the pregnancy period in cases of early-onset fetal growth restriction; however, it was an open-label study. To establ...
Main Authors: | Hiroaki Tanaka, Yasuhiro Tanaka, Yoichi Aoki, Masayuki Endo, Tomoaki Ikeda, Shintaro Maki, Masafumi Nii, Kayo Tanaka, Satoshi Tamaru, Toru Ogura, Yuki Nishimura, Tomomi Kotani, Akihiko Sekizawa, Masahiko Nakata, Koji Nakamura, Kenji Nagao, Ichiro Yasuhi, Hiroshi Kawamura, Sho Takakura, Mayumi Kotera, Takafumi Ushida, Norihiko Kikuchi, Tadatsugu Kinjo, Mayumi Takano, Sachie Suga, Michi Kasai, Osamu Yasui, Yuka Maegawa, Shigeru Aoki, Yoshio Yoshida |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e054925.full |
Similar Items
-
Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
by: Hiroaki Tanaka, et al.
Published: (2019-10-01) -
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
by: Kyoka Tsuchiya, et al.
Published: (2020-12-01) -
Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction
by: Makoto Tsuji, et al.
Published: (2023-05-01) -
Retraction notice to “Maternal blood concentration of tadalafil in pregnancy: Comparison of pregnant and non-pregnant women” [Taiwan J Obstet Gynecol 61 (2022) 230–233]
by: Naosuke Enomoto, et al.
Published: (2023-11-01) -
Tadalafil for Treatment of Fetal Growth Restriction: A Review of Experimental and Clinical Studies
by: Shintaro Maki, et al.
Published: (2024-04-01)